We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A risk assessment of atrazine use in California: human health and ecological aspects.
- Authors
Gammon, Derek W.; Aldous, Charles N.; Carr Jr., Wesley C.; Sanborn, James R.; Pfeifer, Keith F.
- Abstract
A risk assessment of the triazine herbicide atrazine has been conducted by first analyzing the toxicity database and subsequently estimating exposure. Margins of safety (MOS) were then calculated. Toxicity was assessed in animal studies and exposure was estimated from occupational and dietary sources. In acute toxicity studies, atrazine caused developmental toxicity in the rabbit [no observed effect level (NOEL) 5 mg kg-1 day-1] and cardiotoxicity in a dog chronic study (NOEL 0.5 mg kg-1 day-1); cancer (mammary glands) resulted from lifetime exposure. The mammary tumors, which occurred specifically in female Sprague-Dawley rats, were malignant, increased in a dose-dependent manner and were also observed with other, related triazines. Evidence for a genotoxic basis for these tumors was either equivocal or negative. Triazines have been shown to be clastogenic in Chinese hamster ovary cells, in vitro, but without showing a convincing dose/response relationship. Atrazine can be converted into genotoxic N-nitrosoatrazine in the environment or the digestive system, suggesting that N-nitrosamines derived from triazines could be oncogenic. However, it was concluded that N-nitrosotriazines are unlikely to play a significant role in triazine-induced rat mammary gland tumors. An endocrine basis for the mammary tumors, involving premature aging of the female SD rat reproductive system, has been proposed. A suppression of the luteinizing hormone surge during the estrus cycle by atrazine leads to the maintenance of elevated blood levels of 17β-estradiol (E2) and prolactin. The mechanism for tumor development may include one or more of the following: the induction of aromatase (CYP19) and/or other P450 oxygenases, an antagonist action at the estrogen feedback receptor in the hypothalamus, an agonist action at the mammary gland estrogen receptor or an effect on adrenergic neurons in the hypothalamic-pituitary pathway...
- Subjects
ATRAZINE; HERBICIDES; ESTRADIOL; PROLACTIN; ESTROGEN
- Publication
Pest Management Science, 2005, Vol 61, Issue 4, p331
- ISSN
1526-498X
- Publication type
Article
- DOI
10.1002/ps.1000